Showing results (91-100 of 242) with videos related to
Sort By:
Pageof 25
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1976
The production and characterization of antibodies reactive with meperidineB H Wainer, W E Wung, J H Hill, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1976
The production and characterization of antibodies reactive with meperidineB H Wainer, W E Wung, J H Hill, et al.Journal of Medicinal Chemistry|February 1, 1987
Molecular modification of anticholinergics as probes for muscarinic receptors. 1. Amino esters of alpha-substituted phenylacetic acid and related analoguesM C Lu, W E Wung, L B Shih, et al.Cancer Treatment Reports|February 1, 1984
Modulation of cytarabine uptake and toxicity by dipyridamoleM E King, A Naporn, B Young, et al.Somatic Cell and Molecular Genetics|March 4, 2000
Chromosomal localization and genomic structure of the human arsenite-stimulated ATPase (hASNA-I)B Kurdi-Haidar, D Heath, G Lennon, et al.The Journal of Infectious Diseases|September 1, 1990
Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomesS Kim, S Scheerer, M A Geyer, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell lineE Kimura, R E Enns, F Thiebaut, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavityM Markman, S Cleary, W E Lucas, et al.Cancer|November 15, 1985
High-dose intracavitary cisplatin with intravenous thiosulfate. Low incidence of serious neurotoxicityM Markman, S Cleary, C E Pfeifle, et al.Medical and Pediatric Oncology|January 1, 1985
Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusionsM Markman, S Cleary, M E King, et al.Pageof 25